NGL Fine-Chem Limited (NSE:NGLFINE)
India · Delayed Price · Currency is INR 3,055.60
+10.20 (0.33%)
Jun 19, 2026, 3:29 PM IST
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 18.99 billion as of June 18, 2026. Its market cap has increased by 164.65% in one year.
Market Cap
18.99B
Enterprise Value
19.63B
Revenue
5.01B
Ranking
n/a
PE Ratio
39.46
Stock Price
3,055.60
Market Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 18.99B, an increase of 23,522.11%. That is a compound annual growth rate of 28.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 18.99B | 118.18% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.41T |
| Divi's Laboratories | 1.79T |
| Apollo Hospitals Enterprise | 1.22T |
| Cipla | 1.09T |
| Indoco Remedies | 21.69B |
| Beta Drugs | 20.09B |
| Shalby | 18.36B |
| Sakar Healthcare | 17.88B |